Alpibectir (BVL-GSK098) is a transcription factor inhibitor. Alpibectir acts on VirS to increase Ethionamide (HY-B0276) bioactivation via the alternative MymA pathway. Alpibectir augments Ethionamide activity and overcomes ethionamide resistance from EthA mutations. Alpibectir can be used for the research of tuberculosis (tb)[1].
Molekulargewicht:
332.24
Reinheit:
99.81
CAS Nummer:
[2285440-39-1]
Formel:
C12H14F6N2O2
Target-Kategorie:
Bacterial
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten